DOI: 10.1002/cbic.200900480 Efficient Biooxidations Catalyzed by a New Generation of Self-Sufficient Baeyer-Villiger Monooxygenases Daniel E. Torres PazmiÇo, [a, b] Anette Riebel, [a] Jon de Lange, [a] Florian Rudroff, [b] Marko D. Mihovilovic, [b] and Marco W. Fraaije* [a] Over the last decades industrial interest in oxidative biocatalysis has increased significantly. One of the most prominent enzyme families that catalyze a variety of different oxidations are Baeyer-Villiger monooxygenases (BVMOs). These biocatalysts are part of an exclusive family of flavin-dependent enzymes that catalyze the biotransformation of aldehydes and (a)cyclic ketones to their corresponding esters and lactones. [1] Additionally, these enzymes are also known for their capability to oxidize heteroatoms (sulphur, nitrogen, boron) and perform epoxidation reactions. [2] Type I BVMOs utilize flavin adenine dinucleotide (FAD) as cofactor and NADPH as electron donor in order to activate molecular oxygen (O 2 ) and generate a reactive C4a-peroxyflavin intermediate. This enzyme intermediate acts similarly to an organic peracid and reacts with the organic substrate and this results in formation of the oxygenated product. [3] BVMOs have been shown to carry out these oxidative reactions in a highly regio-, stereo-and enantioselective manner; this indicates that these enzymes are interesting candidates for various biocatalytic applications. [4] An obstacle of using BVMOs in a cost efficient way is the requirement of stoichiometric amounts of expensive NADPH coenzyme. Several coenzyme regeneration methods have been explored in the recent years. [5] The most efficient approach is based on the regeneration of NADPH by using a two-enzyme system (either as isolated enzyme or in whole cells). [6] Typically, NAD(P) + -dependent dehydrogenases are applied to regenerate the reduced coenzyme at the expense of a cheaper sacrificial substrate. [7] Phosphite dehydrogenase (PTDH, EC 1.20.1.1) is an excellent example of such NAD(P)H regenerating enzymes. This enzyme catalyzes the thermodynamically driven oxidation of phosphite to phosphate by simultaneous reduction of NAD(P) + . [5c, 8] We have recently investigated the utility of PTDH in combination with BVMOs. By covalently fusing this enzyme to various BVMOs, so-called CRE/BVMOs were created (CRE; coenzyme regenerating enzyme). [9] Advantages of these bifunctional biocatalysts are that 1) with minimum effort in terms of enzyme production and isolation and 2) maximum simplicity with respect to coenzyme regeneration, challenging enzymatic oxidations can be performed. The first generation of these self-sufficient CRE/BVMOs were successfully applied for the bioconversions of a wide variety of substrates by using whole cells, cell-free extracts (CFEs) and purified enzyme. Interestingly, biooxidations using cell-free extracts could be performed without addition of NADPH/NADP + . This can be explained by the fact that sufficient amounts of coenzyme are released for catalysis to occur when the Escherichia coli cells are ruptured.
However, the activity of the first reported self-sufficient BVMOs decreased significantly over time due to instability of the PTDH fusion partner. By a successful combination of sitedirected and random mutagenesis approaches, Zhao and coworkers have been able to improve the thermostability of PTDH, as well as its resistance towards organic solvents. In comparison to the wild-type, this PTDH mutant (18 PTDH) contained 18 mutations and showed a 7000-fold longer life time at 45 8C. [10] In this work we present fusion engineering and biocatalytic studies of a new generation of self-sufficient BVMOs. In comparison to the previous generation, these second generation self-sufficient CRE2/BVMOs posses 1) a thermostable variant of PTDH as fusion partner for effective coenzyme regeneration, 2) a codon-optimized PTDH mutant gene for excellent expression in E. coli, [11] and 3) a histidine purification tag at the free N terminus of the PTDH partner. In this way, the dehydrogenase fusion partner is not only exploited for its ability to efficiently regenerate nicotinamide coenzymes, but also as both expression and purification tag. [12] For this study, six representative BVMOs were selected and fused to the C terminus of the thermostable PTDH variant: cyclopentanone monooxygenase from Comamonas sp. strain NCIMB 9872 (CPMO, EC 1.14.13.16) , [13] cyclohexanone monooxygenase from Acinetobacter sp. NCIMB 9871 (CHMO, EC 1.14.13.22 ), [14] 4-hydroxyacetophenone monooxygenase from Pseudomonas fluorescens ACB (HAPMO, EC 1.14.13.81), [15] ethionamide monooxygenase from Mycobacterium tuberculosis H37Rv (EtaA, EC 1.14.13.92), [16] phenylacetone monooxygenase from Thermobifida fusca (PAMO; EC 1.14.13.92) and the M446G PAMO mutant. [17] Expression levels of all six CRE2/BVMOs in E. coli TOP10 were excellent (see Supporting Information) and subsequent purification was performed in a one step process by using a Ni-NTA column. Even CRE2-CPMO was obtained in good purity while previous attempts to purify CPMO from a recombinant host failed, tentatively due to stability reasons. [13b,c] The activities and kinetic parameters of the isolated CRE2/ BVMOs were determined using the primary substrates of each enzyme. In general, the catalytic activities (k cat ) and Michaelis-Menten constants (K M ) of the BVMOs fused to the thermostable PTDH were found to be very similar to those of the nonfused enzymes ( Table 1 ). The catalytic efficiency (k cat /K M ) of the PTDH subunit for NADP + was found to vary between 93 and 1300 mm À1 s À1 , depending on its fusion partner. The variance in these values may reflect the level of flavin cofactor incorporation in each fused enzyme and are at the same order of magnitude compared to the nonfused PTDH variant (k cat /K M = 2.5 10 2 mm À1 s À1 ). [10c] In order to determine the stability of these new CRE2/ BVMOs, activity measurements were carried out at elevated temperatures. Incubation of CRE2-CHMO at 37 8C resulted in a decrease in BVMO activity over time (t1 = 2 , 37 8C = 95 min), whereas no loss in activity was observed for the PTDH subunit during 24 h. This clearly indicates that the activity and stability of the dehydrogenase is not affected by the thermal inactivation of its fusion partner. Incubation of CRE2-PAMO at 50 8C showed that the PTDH subunit is also suitable for coenzyme regeneration at elevated temperatures, showing a half-life time (t1 = 2 , 50 8C) of 39 h. Additionally, we determined that the PTDH subunit tolerates methanol as organic cosolvent. The initial specific activity of the dehydrogenase subunit of CRE2-PAMO was found to be hardly affected when using up to 40 % methanol. In the presence of 30 % methanol at 30 8C, a slow decrease in dehydrogenase activity was observed (t1 = 2 = 2 h).
Length and composition of peptide linkers are known to affect protein stability and domain-domain interactions of fusion enzymes. [18] All CRE2/BVMOs described above contain a peptide linker consisting of six amino acids, Ser-Arg-Ser-Ala-Ala-Gly. In order to determine whether the linker has an effect on the stability of the fusion between PTDH and a BVMO, we constructed three additional variants of CRE2-PAMO with different linkers. These variants contained a glycine-rich peptide, a "nature-preferred" peptide or a single tryptophan as linker. All four variants of CRE2-PAMO were found to have the same specific activity and thermostability (see Supporting Information). These results indicate that the termini of both enzymes are sufficiently flexible and solvent-exposed to yield an effective and thermostable fusion enzyme, regardless of the nature of the peptide linker between these two subunits.
Previously, we demonstrated that bifunctional CRE/BVMOs can be also applied for bioconversions using whole cells and cell-free extracts. Cell-free extract containing CRE-CHMO was used to catalyze the oxidation of 4-methylcyclohexanone (1) to the corresponding lactone 2 in the presence of phosphite. The biotransformation stopped after a reaction time of 6 h, while less than 40 % conversion was achieved (> 10 mm substrate concentration). [9] Performing the same transformation with the newly created thermostable CRE2-CHMO, resulted in a more effective oxidation of the substrate (Figure 1) .
In contrast to the first generation self-sufficient BVMOs, the thermostable variant CRE2-CHMO showed no inactivation within the presented time frame. This resulted in the full conversion of 5 and 10 mm of ketone 1 within 24 h, yielding > 80 % product 2. Despite possible substrate inhibition, 13 % of conversion was achieved by using 30 mm of ketone 1, while hardly any conversion was observed when CHMO was fused to the relatively thermolabile PTDH. [9] These results confirm that the instability of PTDH in the first reported self-sufficient CRE/ BVMOs was the limiting factor for efficient bioconversions.
Additionally, we investigated the biocatalytic activities of other CRE2/BVMOs in cell-free extract by using bicyclo-[3.2.0]hept-2-en-6-one 3 as a model substrate. At 24 8C, 5 mm of bicyclic ketone 3 was efficiently oxidized to the corresponding lactones 4 and 5 (Scheme 1) by both CRE2-CHMO (100 %) and CRE2-CPMO (85 %). Only 24 % of product formation was observed with CRE2-PAMO after 24 h. At higher substrate concentrations (20 mm), CRE2-CHMO fully converted the bicyclic 2596 www.chembiochem.org ketone 3 within 24 h. On the other hand, hardly any conversion was observed with CRE2-CPMO; this indicates that the CPMO subunit suffers from substrate inhibition. The oxidation rate of ketone 3 by CRE2-PAMO was found to increase proportionally to the substrate concentration, as similar conversion percentages were obtained by using 5 and 20 mm of substrate. This latter observation is in agreement with the low affinity of PAMO towards this bicyclic compound (K M = 15 mm). [17a] Moreover, we studied the biooxidation of bicyclo[3.2.0]hept-2-en-6-one at elevated temperatures. In order to stabilize the BVMO subunit to some extent, we supplemented the reaction mixture with 10 mm FAD. Despite the moderate thermostability of the CHMO subunit (t1 = 2 , 378C = 95 min), CRE2-CHMO was still able to fully convert 5 mm of bicyclic ketone within 3 h at 37 8C. However, at higher temperature (50 8C) the bifunctional enzyme was inactivated within 20 min resulting in a rather poor conversion (21 %). CRE2-PAMO showed a higher catalytic activity at elevated temperatures compared to the reaction performed at 24 8C. Even at 50 8C the fusion enzyme was still active; this indicates that regeneration of NADPH is possible under these conditions. Unfortunately, hardly any conversion was observed using CRE2-CPMO at 37 8C and 50 8C. This is in agreement with the literature which indicates that CPMO is a labile biocatalyst. [13b,c] In this contribution we report on the design, production and evaluation of a new generation of self-sufficient Baeyer-Villiger monooxygenases: CRE2/BVMOs. In comparison to the previous generation, these newly designed bifunctional enzymes contain a multiple mutant of PTDH which has been shown to display a high thermostability. [10c] In addition, the gene of this PTDH mutant was codon-optimized for expression in E. coli. Furthermore, CRE2/BVMOs contain a polyhistidine affinity-tag at their N terminus that facilitates purification of all bifunctional biocatalysts. The purified self-sufficient BVMOs displayed similar kinetic parameters as the nonfused enzymes; this suggests that the properties of these enzymes are hardly affected upon fusion. As expected, their PTDH subunit showed higher (thermo)stability than the dehydrogenase subunit of the first reported self-sufficient BVMOs. Furthermore, these new bifunctional enzymes could be applied as cell-free extracts for conversion of several ketones without loss of activity. Even at elevated temperatures, sufficient regeneration of NADPH took place for the enzyme-catalyzed Baeyer-Villiger oxidation to occur. Based on these results we can conclude that with the thermostable variant of PTDH as fusion-CRE partner, stable and effective self-sufficient BVMOs can be created that have the potential to be applied in biocatalytic processes.
Experimental Section
General methods: Unless otherwise noted, all chemicals and enzymes were obtained from ACROS Organics, Sigma-Aldrich, Jülich Fine Chemicals (Jülich, Germany), Riedel-de Han Fine Chemicals (Seelze, Germany), Roche Applied Sciences, New England Biolabs and Finnzymes (Espoo, Finland) and used without further purification. Oligonucleotide primers were obtained from Sigma Genosys. DNA sequencing was done at GATC Biotech AG (Konstanz, Germa-ny). Synthesis of the 18x ptxD gene was performed by DNA 2.0. The synthetic gene encoding the 18-fold mutant of phosphite dehydrogenase from Pseudomonas stutzeri WM88 was designed by using Gene Designer. [11] The nucleotide sequence of this mutant was optimized using this software tool for optimal codon usage in E. coli. In addition, a His 6 tag was added upstream of the synthetic gene to facilitate enzyme purification. Furthermore, recognition sites for the restriction enzymes NcoI, NdeI and XhoI were introduced to facilitate cloning, whereas PvuII and HindIII restriction sites were avoided.
Cloning strategy: For the creation of pCRE2-PAMO, a modified pBAD vector was used in which the NdeI site was replaced by the original NcoI site. Subsequent cloning of the gene encoding the 18x mutant of phosphite dehydrogenase with N-terminal His-tag (from pJ36/18x PTDH) and the pamO gene by using NcoI/XhoI, respectively PvuII/HindIII, yielded expression vector pCRE2-PAMO. Expression vectors pCRE2-CHMO, pCRE2-CPMO, pCRE2-HAPMO and pCRE2-EtaA were created by subcloning, respectively, the chnB, cpnB, hapE and etaA genes. [13] [14] [15] [16] Expression vector pCRE2-PAMO M446G was created using the QuikChange Site-Directed Mutagenesis Kit of Strategene with pCRE2-PAMO as template and following the recommendations of the manufacturer.
Overexpression and fusion enzyme purification: All self-sufficient BVMOs were overexpressed in E. coli TOP10 by using Terrific Broth (TB) medium containing ampicillin (50 mg mL À1 ) and l-arabinose (0.02 % w/v). CRE2-PAMO (and the linker variants), CRE2-PAMO M446G and CRE2-CHMO were overexpressed at 24 8C during 36 h. CRE2-CPMO, CRE2-HAPMO and CRE2-EtaA were overexpressed at 17 8C during 48 h. Thereafter, cells were harvested, washed and resuspended in Tris/HCl (50 mm, pH 7.5) containing FAD (10 mm). Cells expressing CRE2-CHMO were resuspended in Tris/HCl (50 mm, pH 7.5) supplemented with DTT (0.5 mm) and glycerol (10 % w/v), whereas cells expressing CRE2-EtaA were resuspended in Tris/HCl (50 mm, pH 7.5) supplemented with b-mercaptoethanol (1 mm), NaN 3 (1 mm), KCl (100 mm), glycerol (10 % w/v) and Triton X-100 (1 % v/v) . All further steps were carried out at 4 8C. After breaking the cells by ultrasonication and removing cell debris by centrifugation, fusion enzymes were purified using Ni-NTA (2 mL) column. After purification, excess of imidazole was removed using an Econo-PAC 10DG desalting column (BioRad). The fusion enzymes were concentrated by ultrafiltration and stored at À80 8C.
Determination of kinetic parameters of isolated fusion enzymes:
Activities of purified enzymes were determined spectrophotometrically by monitoring increase or decrease of NADPH in time at 340 (e NADPH = 6.2 mm À1 cm À1 ) or 370 nm (e NADPH = 2.7 mm À1 cm À1 ). The reaction mixture (1 mL) typically contained Tris/HCl (50 mm, pH 7.5), coenzyme (100 mm), ketone (2 mm) or Na 2 HPO 3 (5 mm) and enzyme (0.05-1 mm) at 258C. The following ketones were used: phenylacetone for CRE2-PAMO and CRE2-EtaA, cyclohexanone for CRE2-CHMO, cyclopentanone for CRE2-CPMO, 4-hydroxyacetophenone for CRE2-HAPMO and benzaldehyde for CRE2-PAMO M446G . Kinetic parameters were obtained by fitting the obtained data as described previously. [19] Thermostability of the enzymes was determined by incubating approximately 30 mm enzyme at 37 or 50 8C, after which their remaining activity was determined at 25 8C using saturating substrate concentrations.
General protocol for cell-free extract (CFE) biotransformations: Fresh TB medium (0.2 or 0.5 L) containing ampicillin (50 mg mL À1 ) was inoculated with 1 % of an overnight preculture of recombinant E. coli TOP10 overexpressing CRE2-PAMO, CRE2-CHMO or CRE2-CPMO in a baffled Erlenmeyer flask (1 or 2.5 L). l-Arabinose (final www.chembiochem.org concentration 0.02 % (w/v)) was added and the culture was incubated at 120 rpm at 24 8C on an orbital shaker for 24 or 40 h, depending on the total volume. Cells were harvested by centrifugation (6000 g, 10 min, 4 8C, Sigma 3 K30 centrifuge, rotor 19777). The cell pellets were resuspended in PBS buffer (10 mm, pH 7.4, double volume of cells) containing PMSF (0.1 %, v/v) and disintegrated by ultrasonication. Cell debris was removed by centrifugation (15 000 g, 20 min, 4 8C, Sigma 6 K15 centrifuge, rotor 372/C). The CFE was divided into aliquots (0.5 mL) and stored at À20 8C until needed. Protein concentration of the cell-free extract was estimated by Bradford method using Protein Assay (Bio-Rad). Biotransformations using CFE were realized in either regular 96-well or 12well plates. The total reaction volume in each well was 150 mL or 2 mL, and contained protein (approximately 8 mg mL À1 ) and Na 2 HPO 3 (100 mm, final concentrations). Substrate inhibition studies were performed by using 4-methylcyclohexanone (5-30 mm) .
Other biotransformations were carried out by using racemic bicyclo[3.2.0]hept-2-en-6-one as substrate (5 or 20 mm) . The mixture was incubated at 700 rpm at 24 8C in a multi-well plate incubator (Heidolph Titramax 1000, Heidolph Instruments, Schwabach, Germany). All biotransformations carried out at elevated temperatures (37 and 50 8C) were supplemented with FAD (10 mm, final concentration). Samples were taken in regular intervals, extracted with ethylacetate including internal standard (1 mm of methyl benzoate) and analyzed by gas chromatography. [20] 
